These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dopaminergic regulation of striatonigral tachykinin and dynorphin gene expression: a study with the dopamine uptake inhibitor GBR-12909. Sivam SP Brain Res Mol Brain Res; 1996 Jan; 35(1-2):197-210. PubMed ID: 8717356 [TBL] [Abstract][Full Text] [Related]
3. Dopaminergic modulation of serotonin metabolism in rat striatum: a study with dopamine uptake inhibitor GBR-12909. Sivam SP Life Sci; 1995; 56(26):PL467-72. PubMed ID: 7540709 [TBL] [Abstract][Full Text] [Related]
4. D1 dopamine receptor-mediated substance P depletion in the striatonigral neurons of rats subjected to neonatal dopaminergic denervation: implications for self-injurious behavior. Sivam SP Brain Res; 1989 Oct; 500(1-2):119-30. PubMed ID: 2481560 [TBL] [Abstract][Full Text] [Related]
5. Behavioral and neurochemical recovery from partial 6-hydroxydopamine lesions of the substantia nigra is blocked by daily treatment with D1/D5, but not D2, dopamine receptor antagonists. Emmi A; Rajabi H; Stewart J J Neurosci; 1997 May; 17(10):3840-6. PubMed ID: 9133402 [TBL] [Abstract][Full Text] [Related]
6. Early increase in dopamine release in the ipsilateral striatum after unilateral intranigral administration of lactacystin produces spontaneous contralateral rotations in rats. Konieczny J; Lenda T; Czarnecka A Neuroscience; 2016 Jun; 324():92-106. PubMed ID: 26964686 [TBL] [Abstract][Full Text] [Related]
8. Dopamine, serotonin and tachykinin in self-injurious behavior. Sivam SP Life Sci; 1996 May; 58(26):2367-75. PubMed ID: 8691981 [TBL] [Abstract][Full Text] [Related]
9. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767 [TBL] [Abstract][Full Text] [Related]
10. Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat: 2. Intracerebral microinjection of dopamine agonists and antagonists. Okamura H; Murakami T; Yokoyama C; Nakamura T; Ibata Y J Pharmacol Exp Ther; 1997 Feb; 280(2):1031-7. PubMed ID: 9023320 [TBL] [Abstract][Full Text] [Related]
11. Effect of 1,2,3,4,-tetrahydroisoquinoline administration under conditions of CYP2D inhibition on dopamine metabolism, level of tyrosine hydroxylase protein and the binding of [3H]GBR 12,935 to dopamine transporter in the rat nigrostriatal, dopaminergic system. Lorenc-Koci E; Antkiewicz-Michaluk L; Wardas J; Zapała M; Wierońska J Brain Res; 2004 May; 1009(1-2):67-81. PubMed ID: 15120584 [TBL] [Abstract][Full Text] [Related]
12. Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat: 1. Dopaminergic neurons and receptors. Yokoyama C; Okamura H J Pharmacol Exp Ther; 1997 Feb; 280(2):1016-30. PubMed ID: 9023319 [TBL] [Abstract][Full Text] [Related]
13. Differential reinforcing effects of cocaine and GBR-12909: biochemical evidence for divergent neuroadaptive changes in the mesolimbic dopaminergic system. Tella SR; Ladenheim B; Andrews AM; Goldberg SR; Cadet JL J Neurosci; 1996 Dec; 16(23):7416-27. PubMed ID: 8922397 [TBL] [Abstract][Full Text] [Related]
14. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation. Hu XT; White FJ Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677 [TBL] [Abstract][Full Text] [Related]
15. Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain. Karoum F; Chrapusta SJ; Brinjak R; Hitri A; Wyatt RJ Br J Pharmacol; 1994 Dec; 113(4):1391-9. PubMed ID: 7889297 [TBL] [Abstract][Full Text] [Related]
16. Subacute toluene exposure increases DA dysfunction in the 6-OH dopamine lesioned nigrostriatal dopaminergic system of the rat. Cintra A; Andbjer B; Finnman UB; Hagman M; Agnati LF; Höglund G; Fuxe K Neurosci Lett; 1996 Oct; 217(1):61-5. PubMed ID: 8905740 [TBL] [Abstract][Full Text] [Related]
17. [Microdialysis study of tolcapone effect during blockage of neuronal dopamine reuptake caused by GBR-12909]. Budygin EA; Gaĭnetdinov RR; Raevskiĭ KS; Li IH; Mannisto PT Eksp Klin Farmakol; 1997; 60(5):8-10. PubMed ID: 9483396 [TBL] [Abstract][Full Text] [Related]
18. Effect of chronic ceruletide treatment on dopaminergic neurotransmitters, receptors and their mRNAs in the striatum of rats with dyskinesia induced by iminodipropionitrile. Hirata H; Ogawa N; Asanuma M; Ota Z; Mori A Brain Res; 1993 Feb; 604(1-2):197-204. PubMed ID: 8457848 [TBL] [Abstract][Full Text] [Related]
19. Halothane anesthesia enhances the effect of dopamine uptake inhibition on interstitial levels of striatal dopamine. Fink-Jensen A; Ingwersen SH; Nielsen PG; Hansen L; Nielsen EB; Hansen AJ Naunyn Schmiedebergs Arch Pharmacol; 1994 Sep; 350(3):239-44. PubMed ID: 7824039 [TBL] [Abstract][Full Text] [Related]
20. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats. Hossain MA; Weiner N J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]